Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 250

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 250
---
| Series A Preferred Stock accretion                                                                           | ​ |           — | ​ | ​           |  1,153,846 | ​ | ​ |         — | ​ | ​      |   — | ​ | ​          |  -1,153,846 | ​ | ​           |           — | ​ | ​     | -1,153,846 |
| Series A Preferred Stock dividends                                                                           | ​ |           — | ​ | ​           |    249,701 | ​ | ​ |         — | ​ | ​      |   — | ​ | ​          |    -249,701 | ​ | ​           |           — | ​ | ​     |   -249,701 |
| Preferred Stock redemption including cash premium                                                            | ​ |      -1,154 | ​ | ​           | -1,279,016 | ​ | ​ |         — | ​ | ​      |   — | ​ | ​          |     -89,531 | ​ | ​           |           — | ​ | ​     |    -89,531 |
| Net loss                                                                                                     |   |           — | ​ | ​           |          — | ​ | ​ |         — | ​ | ​      |   — | ​ | ​          |           — | ​ | ​           |  -8,481,338 | ​ | ​     | -8,481,338 |
| Balance, September 30, 2023                                                                                  |   |      13,846 | ​ | $           |    124,531 | ​ | ​ | 2,119,620 | ​ | $      | 211 | ​ | $          | 106,140,063 | ​ | $           | -99,207,731 | ​ | $     |  6,932,543 |

The accompanying Notes are an integral part of the Unaudited Condensed Consolidated Financial Statements.

F-35

PETROS PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

| ​                                                                                
 ​                                                                                
 ​                                                                                
 Cash flows from operating activities:                                            | ​ | ​                                       
 For the Nine Months Ended September 30, 
 2024                                    
 ​                                       |          ​ | ​ | ​    
 2023 
 ​    |           ​ |
|:---------------------------------------------------------------------------------|:--|:----------------------------------------|-----------:|:--|:-----|------------:|
| Net loss